| Debra Holguin, PHARMD | |
|
1550 Town Center Dr, Montebello, CA 90640-2173 | |
| (323) 724-7001 | |
| Not Available |
| Full Name | Debra Holguin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1550 Town Center Dr, Montebello, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356888150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 42334 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra Holguin, PHARMD 1550 Town Center Dr, Montebello, CA 90640-2173 Ph: (323) 724-7001 | Debra Holguin, PHARMD 1550 Town Center Dr, Montebello, CA 90640-2173 Ph: (323) 724-7001 |
News Archive
Discriminatory behaviour towards older workers could replace sexual discrimination as one of the most critical workplace issues of the current generation, according research conducted by CQU Professional Doctorate candidate Brad Jorgensen.
One of the treats of summer-fresh, antioxidant-rich blueberries-has new competition for the title of "superfruit." But at least the contenders are keeping the title in the family. Researchers have found that two species of wild blueberries native to the tropical regions of Central and South America-the New World tropics, or Neotropics-contain two to four times more antioxidants than the blueberries sold in U.S. markets.
A novel strategy of blocking the growth of blood vessels with antibodies should result in improved treatment of cancerous tumors.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.
Marking the first major treatment advance since tamoxifen's introduction over 25 years ago, Canada's leading oncologists and breast cancer patient support and advocacy groups gathered to applaud a new era in treatment for early breast cancer.
› Verified 3 days ago
Keumja Yang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3001 W Beverly Blvd, Suite 102, Montebello, CA 90640 Phone: 323-722-0778 Fax: 323-278-1121 | |
Dr. Susan T Fong, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1345 Montebello Blvd, Montebello, CA 90640 Phone: 323-890-0069 Fax: 323-890-9277 | |
Mrs. Shushma Patel, R.PH.,MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 W Whittier Blvd, Montebello, CA 90640 Phone: 323-728-8127 | |
Yizhou Sun, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 Via Campo, Montebello, CA 90640 Phone: 323-724-6340 | |
Janet A Cheng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 309 W Beverly Blvd, Montebello, CA 90640 Phone: 323-726-1222 | |
Julie Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 W Whittier Blvd, Montebello, CA 90640 Phone: 323-727-9117 | |
Waikin Harry Loong, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 W Beverly Blvd, Montebello, CA 90640 Phone: 323-722-3782 |